Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease -- Ignore unavailable to you. Want to Upgrade?

To: john couch who wrote (2611)	7/16/1998 4:24:00 PM
From: Donna L	Read Replies (1) \| Respond to of 3725

I stand corrected and thank you for your response but now you just launched more questions. Hope you don't mind and forgive me if they have already been addressed. If the answers are in the annual report, you can just reference the page to save time. Why are we not perceived as pushing the functional aspect of the equipment? Is that what GE is going to be doing? How does the imaging compare with nuclear technology? Is there reduced pulmonary interference with the scanner? Cost comparison with nuclear equipment and studies? A thallium costs >1k. Why then did we cut a deal with Positron? Isn't that market fairly limited and dominated by Siemans or are we counting on the Japan connection? Did we simply front a loan or are we raising capital for them? Are we heavily marketing the pediatric cardiologists/CV surgeons and hospitals? If my child were going to have a choice between invasive angiography versus CT scanning, I would push my carrier for coverage. Especially given that they will most likely have several depending on the problem. Thank you for your time. I have been reading the posts on Yahoo and the companies silence is deafening! If there was some company presence with solid answers, you would see your current investors (posting on Yahoo) investing more heavily. Thank you for your time. EOM

To: john couch who wrote (2611)	7/16/1998 4:49:00 PM
From: stock bull	Read Replies (1) \| Respond to of 3725

Hi John, I understand that software is now available that allows for the measurement of blockage. I believe the software allows for a "fly through" of the artery. If this is true, won't the scanner replace the cat procedure? Stock Bull

To: john couch who wrote (2611)	7/16/1998 5:12:00 PM
From: art slott	Respond to of 3725

Thanks for the info John. I think a list of some Q & A's should be posted at the Imat website. Since that is where many investors go for info. If they already are we can add the one you just answered and some of these new ones. Art

To: john couch who wrote (2611)	7/16/1998 5:35:00 PM
From: Brian Moloney	Read Replies (1) \| Respond to of 3725

John, I have read the studies about the expanded capabilities using the contrast, but our set-up in town does not yet do that. How many of the US installations are using contrast? How many of the Heartscan installations are using contrast? What additional costs (hardware, software, personnel, etc.) are necessary to get up and running? To me the use of the contrast material for the "non-invasive heart cath" is extraordinary; the pictures are amazing. It seems to me that most of these studies have been done in Germany, but I may be wrong. My impression is that this use of the technology is barely being used in the US.